Buy & Sell BridgeBio Pharma Inc (BBIO) – BridgeBio Pharma Inc Price Today
Aura AI Summary
Key Stats
- $13.26BMarket Cap
- HealthSector
- -17%3M Drawdown
- $14.82BEnterprise Value
- -Dividend Yield
- 74% Buy | 26% SellTrading Activity
- 58 daysTypical Hold Time
BridgeBio Pharma Inc (BBIO) is currently valued at a market capitalization of $13.26B, with an enterprise value of $14.82B. Over the past 52 weeks, BridgeBio Pharma Inc has traded between a low of $32.26 and a high of $79.91, highlighting its annual price range. Over the past three months, BridgeBio Pharma Inc has recorded a drawdown of -17%, reflecting recent price volatility. On average, investors hold BridgeBio Pharma Inc for approximately 58 days, indicating typical investor behavior on the platform.
About BridgeBio Pharma Inc
BridgeBio Pharma Inc is involved in identifying advance transformative medicines to treat patients who suffer from Mendelian diseases, which are diseases that arise from defects in a single gene, and cancers with clear genetic drivers. Its product pipeline categories include Mendelian, Genetic Dermatology, Oncology, and Gene therapy.
Most Recent News
Pepeto presale sells out early, offering a new crypto exchange amid XRP's slow $10 target.
Pepeto's latest presale stage sold out ahead of schedule, attracting new wallets at twice last month's rate without paid promotion. Built by the original Pepe token team, Pepeto offers a zero-fee exchange with AI contract checks across major blockcha...

Powerus advances to Phase II of Pentagon's $1B Drone Dominance Program with MatrixFold attack drone
Powerus has been selected to compete in Phase II of the Pentagon's $1 billion Drone Dominance Program with its MatrixFold multi-purpose attack drone. This program aims to procure tens of thousands of low-cost, one-way attack drones to enhance U.S. mi...

AI-driven factories can boost productivity by 60%, reshaping global manufacturing competitiveness.
AI-enabled factory of the future technologies can increase manufacturing productivity by up to 60%, changing how companies compete globally. This shift means upgrading factories in high-cost countries can be more competitive than offshoring, reducing...
